Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MakeValue is a Japanese medical technology company specializing in the development and manufacture of automated cell culture systems and equipment for regenerative medicine. The company's flagship products, such as the Cell-Pet series, are designed to automate the complex processes of cell processing and cultivation, ensuring high quality and consistency for clinical applications. By providing advanced hardware and software solutions for Cell Processing Centers (CPCs), MakeValue aims to reduce costs and improve the scalability of cell-based therapies. Their technology supports the production of various cell types, including stem cells and immune cells, for use in hospitals and research institutions. The company is a key contributor to the industrialization of regenerative medicine in Japan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Make Value.